Kevin Kimberlin

Kevin Kimberlin is chairman of Spencer Trask & Co. an advanced technology firm. Kimberlin has distinguished himself by partnering with or backing "obsessive missionaries" including Jonas Salk, Walter Gilbert, John Wennberg and Robert Langer.

At the birth of the mobile phenomenon in 1982, Mr. Kimberlin invested in Millicom, the only startup selected by the FCC to demonstrate the feasibility of cellular telephony. He structured the first equity financing for Millicom, which was the impetus for the Racal–Millicom joint venture —subsequently renamed Vodafone Group plc. By August 2000, Vodafone was the largest communications firm and the 7th most valuable public company, with a peak market cap of $404 billion. Today Vodafone serves more than 400 million mobile phone users globally.

Mr. Kimberlin co-founded Ciena Corporation with Dr. David Huber, which commercialized the first dense wave division multiplexing (DWDM) system, powered by Ciena’s patented dual-stage optical amplifier. As the common basis of all high-capacity fiber communications networks around the world, DWDM enabled the explosive growth of the Internet and serves as its foundation today. By 2015, Ciena was the market share leader in high capacity networks with 1,000 customers, making up 80% of the world's largest communications providers.

Prior to its public offering, Kimberlin was the sole general partner of Next Level Communications, a broadband access leader, 20% owned by Kimberlin LLC and 80% owned by General Instrument Corporation. Kimberlin guided Next Level through its IPO, achieving a market capitalization of $17 billion before it was acquired by Motorola in 2002.

In 1986, Kimberlin co-founded the Immune Response Corporation with Jonas Salk. The Immune Response Corporation patented the basis of the first FDA approved cancer vaccine, and pioneered the field of immunotherapy.

He then co-founded Myriad Genetics, the first human genome company, with Nobel Prize winner Dr. Walter Gilbert, Peter Meldrum, and Dr. Mark Skolnick, the scientist who, with several colleagues, devised the gene-mapping technique that catalyzed the Human Genome Project. Myriad Genetics received international acclaim by discovering the breast cancer gene, BRCA1.

...
Wikipedia